TRANYLCYPROMINE (PARNATE) A NEW MONOAMINE OXIDASE INHIBITOR
FREDERICK LEMERE M.D.1
1 The Department of Psychiatry, University of Washington, School of Medicine, Seattle, Washington.
Preliminary clinical experience indicates that tranylcypromine (Parnate) is an improved type of monoamine oxidase inhibitor that appears to be more rapid in its action, effective in smaller doses (1 to 3 tablets a day–usually one tablet b. i. d.) and relatively free of side effects. It is indicated for treatment of any type of depression and sometimes for withdrawn schizophrenic patients.
